FDA Inspection 754952 — Aino Co., Ltd. of North China Pharma. Group
The FDA completed an inspection of Aino Co., Ltd. of North China Pharma. Group on November 18, 2011 in Shijiazhuang, Hebei. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 18, 2011
- Fiscal Year
- 2012
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Shijiazhuang, Hebei (China)